Referenser

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.

  2. Brink M, Cronqvist J, Fagerberg A, Lindgren P, Lipcsey M, Okas M, et al. Nu gäller Sepsis-3 för definitioner och diagnostiska kriterier. Lakartidningen. 2018;115.

  3. Svensk barninfektionsläkarförening. Nationellt vårdprogram för initial handläggning av misstänkt sepsis hos barn 2023 [Available from: https://inf.barnlakarforeningen.se/wp-content/uploads/sites/22/2023/05/Pediatrisk-sepsis-Svenska-riktlinjer-2023-04-27.pdf.

  4. Mellhammar L, Wollter E, Dahlberg J, Donovan B, Olséen CJ, Wiking PO, et al. Estimating Sepsis Incidence Using Administrative Data and Clinical Medical Record Review. JAMA network open. 2023;6(8):e2331168.

  5. Mellhammar L, Wullt S, Lindberg A, Lanbeck P, Christensson B, Linder A. Sepsis Incidence: A Population-Based Study. Open Forum Infect Dis. 2016;3(4):ofw207.

  6. Ljungstrom L, Andersson R, Jacobsson G. Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden - A prospective population-based study. PLoS One. 2019;14(12):e0225700.

  7. Strandberg G, Walther S, Ohman CA, Lipcsey M. Mortality after Severe Sepsis and Septic Shock in Swedish Intensive Care Units 2008-2016-A nationwide observational study. Acta anaesthesiologica Scandinavica. 2020;64(7):967-75.

  8. Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147-57.

  9. Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in us hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318(13):1241-9.

  10. Henriksen DP, Laursen CB, Jensen TG, Hallas J, Pedersen C, Lassen AT. Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med. 2015;43(1):13-21.

  11. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2013;14(7):686-93.

  12. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154-62.

  13. Plunkett A, Tong J. Sepsis in children. BMJ (Clinical research ed). 2015;350:h3017.

  14. Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, et al. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009;37(3):222-32.

  15. Agyeman PKA, Schlapbach LJ, Giannoni E, Stocker M, Posfay-Barbe KM, Heininger U, et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health. 2017;1(2):124-33.

  16. Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017;196(7):856-63.

  17. Holmbom M, Andersson M, Berg S, Eklund D, Sobczynski P, Wilhelms D, et al. Prehospital delay is an important risk factor for mortality in community-acquired bloodstream infection (CA-BSI): a matched case-control study. BMJ open. 2021;11(11):e052582.

  18. Gotmaker R, Peake SL, Forbes A, Bellomo R. Mortality is Greater in Septic Patients With Hyperlactatemia Than With Refractory Hypotension. Shock. 2017;48(3):294-300.

  19. Chen H, Zhao C, Wei Y, Jin J. Early lactate measurement is associated with better outcomes in septic patients with an elevated serum lactate level. Crit Care. 2019;23(1):351.

  20. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e143.

  21. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10-67.

  22. Svenska infektionsläkarföreningen. Nationellt vårdprogram för sepsis och septisk chock 2022 [Available from: https://infektion.net/wp-content/uploads/2022/07/vardprogram_sepsis_maj-2023.pdf.

  23. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-59.

  24. Glimåker M, Johansson B, Bell M, Ericsson M, Bläckberg J, Brink M, et al. Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines. Scand J Infect Dis. 2013;45(9):657-63.

  25. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549-56.

  26. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-27.

  27. Glimåker M, Johansson B, Halldorsdottir H, Wanecek M, Elmi-Terander A, Ghatan PH, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS One. 2014;9(3):e91976.

  28. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147-59.

  29. Information från Läkemedelsverket. Läkemedelsbehandling av bakteriella hud- och mjukdelsinfektioner i öppenvård – behandlingsrekommendation.; 2018.

  30. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333-40.

  31. Brink M, Arnell P, Lycke H, Rosemar A, Hagberg L. A series of severe necrotising soft-tissue infections in a regional centre in Sweden. Acta anaesthesiologica Scandinavica. 2014;58(7):882-90.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida